MARKET

PSNL

PSNL

Personalis
NASDAQ
14.50
+0.34
+2.40%
After Hours: 14.39 -0.11 -0.76% 19:34 08/10 EDT
OPEN
14.09
PREV CLOSE
14.16
HIGH
14.81
LOW
14.02
VOLUME
4.21M
TURNOVER
--
52 WEEK HIGH
16.39
52 WEEK LOW
4.420
MARKET CAP
1.55B
P/E (TTM)
-13.2930
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PSNL last week (0803-0807)?
Weekly Report · 18h ago
HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
Seeking Alpha · 3d ago
Analysts Offer Insights on Healthcare Companies: RxSight (RXST) and Personalis (PSNL)
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), OrthoPediatrics (KIDS) and Sight Sciences (SGHT)
TipRanks · 5d ago
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates
NASDAQ · 6d ago
Personalis says not providing guidance or conducting earnings call
TipRanks · 6d ago
*Personalis 2Q Loss/Shr 30c >PSNL
Dow Jones · 6d ago
*Personalis 2Q Rev $22.4M >PSNL
Dow Jones · 6d ago
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.